Endo Pharmaceuticals Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 1,260.5 | 1,085.6 | 909.7 |
| Cost of Goods Sold | 267.2 | 217.4 | 201.4 |
| Gross Profit | 993.3 | 868.2 | 708.2 |
| Gross Profit Margin | 78.8% | 80.0% | 77.9% |
| SG&A Expense | 488.1 | 411.9 | 340.1 |
| Depreciation & Amortization | 46.4 | 17.4 | 17.5 |
| Operating Income | 410.6 | 353.4 | -- |
| Operating Margin | 32.6% | 32.6% | -- |
| Nonoperating Income | 0.0 | 36.0 | 23.2 |
| Nonoperating Expenses | 14.7 | -- | -- |
| Income Before Taxes | 402.2 | 353.3 | 233.7 |
| Income Taxes | 140.5 | 125.8 | 95.9 |
| Net Income After Taxes | 261.7 | 227.4 | 137.8 |
| Continuing Operations | 261.7 | 227.4 | 137.8 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 261.7 | 227.4 | 137.8 |
| Total Net Income | 261.7 | 227.4 | 137.8 |
| Net Profit Margin | 20.8% | 21.0% | 15.2% |
| Diluted EPS from Total Net Income ($) | 2.12 | 1.69 | 1.03 |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
